MedPath

TRI-PREVIFEM (21 DAY)

TRI-PREVIFEM (21 DAY)

Discontinued
DIN Number

02320096

Drug Class

Human

Market Date

N/A

Company
HC

novopharm limited

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02320096
AIG Number0636783002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
G03AB PROGESTOGENS AND ESTROGENS, SEQUENTIAL PREPARATIONS
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification68:12.00
Health Canada Classification

ACTIVE INGREDIENTS (4)

ETHINYL ESTRADIOLActive
Strength: 0.035 MG
Monograph: ETHINYL ESTRADIOL
NORGESTIMATEActive
Strength: 0.215 MG
Monograph: NORGESTIMATE
NORGESTIMATEActive
Strength: 0.180 MG
Monograph: NORGESTIMATE
NORGESTIMATEActive
Strength: 0.250 MG
Monograph: NORGESTIMATE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.